User Tools

Site Tools


health:covid-19-corona-cures

YouTube Bans Sky News Australia for One Week Over Misinformation

“YouTube has barred Sky News Australia from uploading new content for a week, saying it had breached rules on spreading Covid-19 misinformation,” writes the BBC.

Long-time Slashdot reader Hope Thelps shares their report: YouTube issued a “strike” under its three-strike policy, the last of which means permanent removal. It did not point to specific items but said it opposed material that “could cause real-world harm”.

The TV channel's digital editor said the decision was a disturbing attack on the ability to think freely. Sky News Australia is owned by a subsidiary of Rupert Murdoch's News Corp and has 1.85 million YouTube subscribers. The ban could affect its revenue stream from Google.

A YouTube statement said it had “clear and established Covid-19 medical misinformation policies based on local and global health authority guidance”. A spokesperson told the Guardian it “did not allow content that denies the existence of Covid-19” or which encouraged people “to use hydroxychloroquine or ivermectin to treat or prevent the virus”. Neither has been proven to be effective against Covid.

Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19

In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the discovery of ivermectin (IVM), a multifaceted drug deployed against some of the world’s most devastating tropical diseases. Since March 2020, when IVM was first used against a new global scourge, COVID-19, more than 20 randomized clinical trials (RCTs) have tracked such inpatient and outpatient treatments. Six of seven meta-analyses of IVM treatment RCTs reporting in 2021 found notable reductions in COVID-19 fatalities, with a mean 31% relative risk of mortality vs. controls. During mass IVM treatments in Peru, excess deaths fell by a mean of 74% over 30 days in its ten states with the most extensive treatments. Reductions in deaths correlated with the extent of IVM distributions in all 25 states with p < 0.002. Sharp reductions in morbidity using IVM were also observed in two animal models, of SARS-CoV-2 and a related betacoronavirus. The indicated biological mechanism of IVM, competitive binding with SARS-CoV-2 spike protein, is likely non-epitope specific, possibly yielding full efficacy against emerging viral mutant strains.

Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study

Although there was no statistically significant difference in any endpoints by ivermectin doses (12 mg/day for 3 days); there was an observed trend to reducing hospital stay in the ivermectin-treated group.

Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic

Early addition of Ivermectin to standard care is very effective drug for treatment of COVID-19 patients with significant reduction in mortality,rt-PCR conversion days , recovery time hospital stay compared to Hydroxychloroquine plus standard care. Early use of Ivermectin is very useful for controlling COVID 19 infections; prophylaxis and improving cytokines storm

Ivermectin and outcomes from Covid-19 pneumonia: A systematic review and meta-analysis of randomized clinical trial studies

Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype

Effect of Early Treatment with Ivermectin among Patients with Covid-19

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities

Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial

Misleading clinical evidence and systematic reviews on ivermectin for COVID-19 Free

Unethical studies of ivermectin for covid-19

Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials

US Insurer Spending on Ivermectin Prescriptions for COVID-19

Efficacy of single-dose and double-dose ivermectin early treatment in preventing progression to hospitalization in mild COVID-19: A multi-arm, parallel-group randomized, double-blind, placebo-controlled trial

efficacy

Expression of Concern for Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021;28(3): e299–e318

The Effect of Ivermectin on Reducing Viral Symptoms in Patients with Mild COVID-19

The Sun could help you fight Covid

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19A Randomized Clinical Trial

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study

Ivermectin as a potential treatment for mild to moderate COVID-19 – A double blind randomized placebo-controlled trial

Ivermectin: an award-winning drug with expected antiviral activity against COVID-19

The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19

Fasten the Nutrients!! Flatten the Pandemic!! -Core Contribution of Medical Nutrition Therapy in COVID-19

IL-17A and Covid and garlic and goji berry.

Early immune responses may be why younger people get less sick from COVID-19 and IL-17A

Why the Coronavirus Hits Kids and Adults So Differently

Why Children Seem to Be Less Affected by the Coronavirus

Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers

The Open-Air Treatment of PANDEMIC INFLUENZA

Inactivation of influenza virus by solar radiation

Getting More Sun Could Protect You from the Flu — Here’s Why

Want to Protect Yourself From Getting the Flu? Get Some Sunshine

Sunlight and Protection Against Influenza

SUNLIGHT AND PROTECTION AGAINST INFLUENZA

Flu: Stop it before it stops you! Sunlight is the key.

The Open-Air Treatment of pandemic influenza

The Influence of Simulated Sunlight on the Inactivation of Influenza Virus in Aerosols

Coronavirus treatment: Bangladesh doctors claim to have found drug combinations to treat COVID-19

'Could It Work as a Cure? Maybe.' A Herbal Remedy for Coronavirus Is a Hit in Africa, But Experts Have Their Doubts

Herbal Cures for COVID-19 Spreading in Tanzania Despite No Evidence They Work

Found effective drug combination to cure Covid-19 patients: Bangladeshi doctors

WHO to study Madagascar's drug to treat COVID-19

health/covid-19-corona-cures.txt · Last modified: 2022/08/07 22:11 by wikiadmin